SERVICES

BIOMARKER DISCOVERY

Pathological changes appear in any diseased tissue and impact different cells within a position dynamically. Leverage our expertise to strengthen and accelerate biomarker discovery and drug development programs. Evaluate clinical values for molecular pathogenesis to uncover disease-specific biomarkers. Our standardized sample processing and data analysis can be the key to translating spatial omics from bench to clinic.

I/O TARGETED DRUG DEVELOPMENT

The tumor microenvironment (TME) is organized in a spatial manner. OMAPiX expertise can delineate TME at an unprecedented level to view the spatial interaction with better prognostic power than existing biomarkers. With deep molecular analysis, we can help you decode the TME ecosystem and expedite your research into an entirely new paradigm. Our services can help you with novel immunotherapy designs for precision medicine. Partner with us to spatially quantify the TME structure and understand the key differences between responders from non-responders, treated and untreated, diseased, and healthy.

CELL AND GENE THERAPY (CGT)

OMAPiX expertise in spatial transcriptomic and proteomic analysis is vital to shed light on some of the critical questions facing the CGT therapeutic modality. Partner with us for spatial omics analysis to better understand:

  • Biodistribution of the genetic payload
  • Target identification, engagement, cytotoxicity and specificity
  • Longitudinal stability of the gene therapy and therapeutic response
  • Mechanisms behind responders and non-responders
  • Mechanisms behind T-cell penetration and exhaustion in solid tumors